Ajanta Pharma Ltd.
Snapshot View

1187.70 +23.65 ▲2.0%

07 February 2023, 04:01:00 PM
Volume: 3,223

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ajantapharma.com
Market Cap 15,217.42 Cr.
Enterprise Value(EV) 14,885.34 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 48.15 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 24.67 Trailing Twelve Months Ending 2022-12
Industry PE 32.80 Trailing Twelve Months Ending 2022-12
Book Value / Share 291.74 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.07 Calculated using Price: 1,187.70
Dividend Yield 0.53 Period Ending 2022-03
No. of Shares Subscribed 12.81 Cr. 128,125,155 Shares
FaceValue 2
Company Profile
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. Emerging markets are the major contributors in company's branded generic business where it is present across Asia and Africa. It has designed customised basket of products for each of these markets and serve wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.03%
1 Week
-1.71%
1 Month
-0.01%
3 Month
-4.71%
6 Month
-7.12%
1 Year
-16.02%
2 Year
-1.77%
5 Year
+33.92%
10 Year
+1063.16%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 47.47 43.24 40.93 36.77 26.00 18.07 19.32 23.38 22.77
Return on Capital Employed (%) 54.52 56.43 51.59 45.72 34.49 23.84 27.44 32.20 29.37
Return on Assets (%) 28.05 29.57 31.66 30.69 22.06 14.52 14.44 17.03 16.79

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 593 841 1,191 1,568 2,041 2,245 2,599 2,996 3,264 3,603
Non Curr. Liab. 81 56 29 9 39 162 228 275 279 65
Curr. Liab. 275 250 260 247 346 498 746 839 838 705
Minority Int.
Equity & Liab. 949 1,146 1,479 1,823 2,426 2,906 3,572 4,109 4,381 4,373
Non Curr. Assets 429 513 716 973 1,202 1,605 1,791 1,891 1,926 1,725
Curr. Assets 520 633 763 851 1,224 1,301 1,781 2,218 2,455 2,649
Misc. Exp. not W/O
Total Assets 949 1,146 1,479 1,823 2,426 2,906 3,572 4,109 4,381 4,373

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,208 1,474 1,734 1,983 2,126 2,055 2,588 2,890 3,341 3,731
Other Income 14 17 21 24 24 21 92 26 116 138
Total Income 1,222 1,490 1,755 2,007 2,150 2,076 2,680 2,916 3,457 3,869
Total Expenditure -840 -968 -1,147 -1,296 -1,467 -1,489 -1,905 -1,891 -2,412 -2,937
PBIDT 382 522 608 711 683 588 776 1,025 1,045 932
Interest -9 -6 -5 -1 0 -1 -12 -8 -10 -12
Depreciation -44 -52 -44 -61 -60 -72 -96 -116 -125 -129
Taxation -96 -146 -143 -141 -154 -127 -196 -246 -197 -174
Exceptional Items -8 -4
PAT 234 310 416 507 469 387 468 654 713 617
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 234 310 416 507 469 387 468 654 713 617
Adjusted EPS 18 23 31 38 36 30 36 50 56 48

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 234 212 279 326 609 281 375 457 576 562
Cash Fr. Inv. -104 -188 -158 -209 -383 -256 -223 -224 -282 -74
Cash Fr. Finan. -104 -20 -105 -117 -202 0 -147 -129 -318 -460
Net Change 26 4 16 0 24 25 4 104 -24 28
Cash & Cash Eqvt 34 39 54 41 66 91 95 199 178 205

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 70.34 70.34 70.34 70.34 70.34 70.48 70.48 70.48 66.11
Public 29.66 29.66 29.66 29.66 29.66 29.52 29.52 29.52 33.89
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 15.17 15.49 14.95 13.73 15.37 16.60 20.09 17.42 19.87

Announcements View Details >>

Tue, 07 Feb 2023
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Further to our letter dated 1st February 2023 please find enclosed herewith Postal Ballot Notice together with the Explanatory Statement seeking approval of members of the Company for reappointment and remuneration of Mr. Yogesh Agrawal as the Managing Director and Mr. RajeshAgrawal as the Joint Managing Director.The Postal Ballot notice has been sent by e-mail on 7th February 2023 to the members who have registered their e-mail IDs with Depository Participant(s) or with the Company. E-voting period will commence from Wednesday 8th February 2023 IST at 9.00 a.m. and will end on Thursday 9th March 2023 IST at 5.00 p.m.
Thu, 02 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 audio call recording of the earnings call held on 1st February 2023 at 4.00 p.m. has been uploaded on the Companys website and can be accessed through the link https://ajantapharma.com//images/EarningsCallAudioQ3(Oct-Dec)2022-23.mp3
Thu, 02 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Listing Regulations please find enclosed copies of financial results of the Company for the quarter and nine months ended 31st December 2022 published in the following newspapers on 2nd February 2023:1. Mumbai edition of Economic Times and2. Mumbai edition of Maharashtra Times.

Technical Scans View Details >>

Tue, 07 Feb 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Closing Near 50 SMA Closing Near 50 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,005.65 -1.7%
Cipla Ltd. 83,244.79 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,441.90 +2.1%
Divi's Laboratories Ltd. 72,982.62 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. 51,953.07 1,533.45 -0.4%
Zydus Lifesciences Ltd. 48,525.07 479.40 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 31.56 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 479.40 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 3.67 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 479.40 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.40 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.40 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.40 +2.0%

FAQ's On Ajanta Pharma Ltd.

What is Ajanta Pharma share price?

Can I buy Ajanta Pharma shares now?

What is the Dividend Yield of Ajanta Pharma?

What is the Market Cap of Ajanta Pharma?

What are the key metrics to analyse Ajanta Pharma?

What is the 52 Week High and Low of Ajanta Pharma?

What is the trend of Ajanta Pharma share price?